Ad hoc coronary intervention

Catheterization and Cardiovascular Interventions

Volumn 49, Issue 2, 2000, Pages 130-134

  Blankenship, James C ^a   Mishkel, Gregory J ^b   Chambers, Charles E ^c   Hodgson, John McB ^d   Holmes, David R ^e   Sheldon, William ^f   Schweiger, Marc J ^g   Cowley, Michael J ^h   Popma, Jeffrey J ⁱ  

^a GEISINGER MEDICAL CENTER   (United States)

^b Prairie Cardiovascular Consultants Ltd   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d METROHEALTH MEDICAL CENTER   (United States)

^e MAYO CLINIC   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g BAYSTATE MEDICAL CENTER   (United States)

^h VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Angioplasty; Complications; Policy

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE;

ARTICLE; CORONARY STENT; COST; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INFORMED CONSENT; MEDICAL DECISION MAKING; MEDICAL ETHICS; PATIENT SATISFACTION; PREOPERATIVE CARE; RISK ASSESSMENT; SAFETY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

COST-BENEFIT ANALYSIS; HEART CATHETERIZATION; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PATIENT SATISFACTION; REPRODUCIBILITY OF RESULTS; SAFETY;

EID: 0033959785     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-726X(200002)49:2<130::AID-CCD3>3.0.CO;2-T     Document Type: Article

References (25)

1. O'Keefe JH, Reeder GS, Miller GA, Bailey KR, Holmes DR. Safety and efficacy of percutaneous transluminal coronary angioplasty performed at time of diagnostic catheterization compared with that performed at other times. Am J Cardiol 1989;63:27-29.
2. O'Keefe JH, Gernon C, McCallister BD, Ligon RW, Hartzler GO. Safety and cost effectivelness of combined coronary angiography and angioplasty. Am Heart J 1991;122:50-54.
3. Rozenman Y, Gilon D, Zelingher J, Lotan C, Mosseri M, Geist M, Weiss AT, Hasin Y, Gotsman MS. One-stage coronary angiography and angioplasty. Am J Cardiol 1995;75:30-33.
4. Haraphongse M, Tymchak W, Rossal RE. Coronary angioplasty at the time of initial diagnostic coronary angiography in patients with unstable angina. Cathet Cardiovasc Diagn 1988;14:73-75.
5. Adele C, Vaitkus PL, Wells SK, Zehnacker JB. Cost advantages of an ad hoc angioplasty strategy. J Am Coll Cardiol 1998;31:321-325.
6. Breisblatt WM, Ruffner RJ, Uretsky BF, Reddy PS. Same-day angioplasty and diagnostic catheterization: safe and effective but riskier in unstable angina. Angiology 1991;8:607-613.
7. Kimmel SE, Berlin JE, Hennessy S, Strom BL, Krone RJ, Laskey WK. Risk of major complications from coronary angioplasty performed immediately after diagnostic coronary angiography: results from the Registry of the Society for Cardiac Angiography and Interventions. Am J Cardiol 1997;30:193-200.
8. Feldman RL, Macdonald RG, Hill JA, Conti R, Pepine CJ, Carmichael MJ, Knauff DG, Alexander JA. Coronary angioplasty at the time of initial cardiac catheterization. Cathet Cardiovasc Diagn 1986;12:219-222.
9. Myler RK, Stertzer SH, Clark DA, Shaw RE, Fishman-Rosen J, Murphy MC. Coronary angioplasty at the time of initial cardiac catheterization. Cathet Cardiovasc Diagn 1986;12:213-214.
10. Schuhlen H, Kastrati A, Dirschlinger J, Hausleiter J, Elezi S, Wehinger A, Pache J, Hadamitzky M, Schomig A. Intracoronary stenting and risk for major cardiac adverse events during the first month. Circulation 1998;98:104-111.
11. Steinhubl SR, Balog C, Topol EJ. Pretreatment with ticlopidine prior to stenting is associated with a substantial decrease in complications: data from the EPISTENT trial. Circulation 1998;98: 1573.
12. Sharis PJ, Cannon CP, Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Int Med 1998;129:394-405.
13. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KKL, Giambartolomei A, Diver DJ, Lasorda DM, Wiliams DO, Pocock SJ, Kuntz RE. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 1998;339: 1665-1671.
14. DeLuca SA, Korcuska LA, Oberstar BH, Rosenthal ML, Welsh PA, Topol EJ. Are we promoting true informed consent in cardiovascular clinical trials? J Cardiovasc Nurs 1995;9:54-61.
15. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL. Guidelines for percutaneous transluminal coronary angioplasty. Circulation 1988;78:486-502.
16. Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB, McAllister BD, Smith SC, Ullyot DJ. Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1993;22: 2033-2054.
17. Lund GK, Nienaber CA, Hamm CW, Terres W, Kuck KH. One session diagnostic heart catheterization and balloon dilatation-("prima-vista" PTCA: results and risks). Deutsche Medizinische Wochenschrift 1994;119:169-174.
18. Cigarroa RG, Lange RA, Williams RH, Hillis D. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989;86:649-652.
19. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Shimshak TM, Hartzler GO. High-dose contrast agent administration during complex coronary angioplasty. Am Heart J 1990; 120:533-536.
20. Friedman HZ, Cragg DR, Glazier SM, Gangadharan V, Marsalese DL, Schreiber TL, O'Neill WW. Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty. J Am Coll Cardiol 1994;24:1214-1219.
21. Mandak JS, Blankenship JC, Gardner LH, Berkowitz SD, Aguirre FV, Sigmon KN, Timmis GC, Gilchrist IC, McIvor M, Resar J, Weiner BH, George BS, Talley JD, Lincoff AM, Tcheng JE, Califf RM, Topol EJ. Modifiable risk factors for vascular access site complications in the IMPACT II trial of angioplasty with versus without Eptifibitide et al. J Am Coll Cardiol 1998;31:1518-1524.
22. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. New York: Oxford University Press; 1989.
23. Hill JA. Single-stage coronary angiography and angiopasty: a new standard? Am J Cardiol 1995;75:75-76.
24. Lane DM. Combined angiography: angioplasty may not be safe, easier on the patient, or more cost-effective. Am J Cardiol 1995;76:641.
25. Technology Marketing Group. Cardiac Cath Lab Operating Results. Des Plaines, IL: Technology Marketing Group; 1995.